As the UK gears up for November's Mouth Cancer Action Week, free accompanying Blue Ribbon Badge Appeal kits are available for all. Campaign organisers the British Dental Health Foundation urge dental practices, doctor's surgeries, health centres hospitals and pharmacies to claim their free kit before the campaign kicks off, November 16th-22nd. Complete news at...
STUTTGART, GERMANY (UroToday.com) - The prognostic value of tumor architecture (papillary versus solid) in 1,363 patients with transitional cell carcinoma of the upper urinary tract was investigated by 12 institutions. A papillary architecture was seen in 72.1% of radical nephroureterectomy specimens. Patients with solid architecture of the tumor had a higher tumor stage, higher grading, higher rate of positive lymph nodes and higher rate of lymphovascular invasion. Complete news at...
BERKELEY, CA (UroToday.com) - Why were these results achievable? This study was planned and initiated in 1992 while Dr. Veltri was serving as Vice President & GM for Research and Development of the UroCor Inc. in collaboration with Drs. Don Coffey, Jonathan Epstein and Alan Partin of the Johns Hopkins University School of Medicine. Complete news at...
College students often spend their free time thinking about beer, but a group of Rice University students are taking it to the next level. They're using genetic engineering to create beer that contains resveratrol, a chemical in wine that's been shown to reduce cancer and heart disease in lab animals. Rice's "BioBeer" will be entered in the International Genetically Engineered Machine (iGEM) competition Nov. 8-9 in Cambridge, Mass. Complete news at...
STUTTGART, GERMANY (UroToday.com) - The value of PCA3 in urine was investigated in a prospective European trial on 463 patients who had previously undergone one or two negative prostate biopsies and who were scheduled for a re-biopsy of their prostate. In 128 patients prostate cancer was found on re-biopsy. The area under the curve was 0.658 for PCA3 compared to 0.578 for free PSA. Complete news at...
Friday, October 17, 2008
Surviving Cancer
The diagnosis of cancer for anyone is devastating. When we first hear the word 'cancer' we are in shock and disbelief. We feel we have just been handed a death sentence. Surviving is a strong instinct in mankind and we have the potential to overcome many challenges, beat incredible odds, and come out a survivor. With the proper attitude anything is possible. Sadly, many of us accept the diagnoses and prescribed treatment of our disease without seeking additional forms of life-saving medicines or treatments.
Degradation And Low Levels Of Bioactive B-Type Natriuretic Peptide (BNP) In Patients With Heart Failure
A team of researchers from Intrinsic Bioprobes Inc. has reported on a novel quantitative mass spectrometry immunoassay for the detection of bioactive B-type natriuretic peptide (BNP), in an article published online on Oct. 14 in the journal of Circulation: Heart Failure. In collaboration with colleagues from Scios Inc. in Fremont, Christ Hospital in Cincinnati, and Medivation Inc. More at...
The University of Pittsburgh School of Medicine is conducting a research study to examine the role sleep plays in the functioning of married couples and their risk of developing cardiovascular disease. Given that spouses are the primary sources of both support and conflict for most adults, the marital relationship offers a critical window for understanding how the ups and downs of these relationships can influence sleep and cardiovascular health. More at...
Researchers at the University of California, San Diego School of Medicine have identified a critical metabolic "switch" in fruit flies that helps oxygen-deprived cells survive. Hypoxia-induced injury occurs in the case of heart attack, stroke or other neurological or respiratory conditions which diminish the supply of oxygen to vital tissues and organs. More at...
Berlin Heart Inc. today announced its EXCOR(R) Pediatric ventricular assist device (VAD) has received unconditional approval for the ongoing IDE clinical trial in the United States of America. The U.S Food and Drug Administration (FDA) has fully approved the Investigational Plan for the IDE study of the device. More at...
Berlin Heart Inc. announced its EXCOR(R) Pediatric ventricular assist device (VAD) has received unconditional approval for the ongoing IDE clinical trial in the United States of America. The U.S Food and Drug Administration (FDA) has fully approved the Investigational Plan for the IDE study of the device. More at...
Abbott (NYSE: ABT) announced two-year data from 30 patients in its ABSORB clinical trial, demonstrating that its bioabsorbable drug eluting stent successfully treated coronary artery disease and was absorbed into the walls of treated arteries within two years, leaving behind blood vessels that appeared to move and function similar to unstented arteries. More at...
Two new articles examine the theory of "fetal programming" and their effect on racial health disparities. The studies, published in American Journal of Human Biology, suggest that the higher rates of hypertension and cardiovascular disease present in African Americans may be a consequence of low birth weights, and that these low birth weights may be a result of social rather than genetic factors. More at...
The University of Pittsburgh School of Medicine is conducting a research study to examine the role sleep plays in the functioning of married couples and their risk of developing cardiovascular disease. Given that spouses are the primary sources of both support and conflict for most adults, the marital relationship offers a critical window for understanding how the ups and downs of these relationships can influence sleep and cardiovascular health. More at...
Researchers at the University of California, San Diego School of Medicine have identified a critical metabolic "switch" in fruit flies that helps oxygen-deprived cells survive. Hypoxia-induced injury occurs in the case of heart attack, stroke or other neurological or respiratory conditions which diminish the supply of oxygen to vital tissues and organs. More at...
Berlin Heart Inc. today announced its EXCOR(R) Pediatric ventricular assist device (VAD) has received unconditional approval for the ongoing IDE clinical trial in the United States of America. The U.S Food and Drug Administration (FDA) has fully approved the Investigational Plan for the IDE study of the device. More at...
Berlin Heart Inc. announced its EXCOR(R) Pediatric ventricular assist device (VAD) has received unconditional approval for the ongoing IDE clinical trial in the United States of America. The U.S Food and Drug Administration (FDA) has fully approved the Investigational Plan for the IDE study of the device. More at...
Abbott (NYSE: ABT) announced two-year data from 30 patients in its ABSORB clinical trial, demonstrating that its bioabsorbable drug eluting stent successfully treated coronary artery disease and was absorbed into the walls of treated arteries within two years, leaving behind blood vessels that appeared to move and function similar to unstented arteries. More at...
Two new articles examine the theory of "fetal programming" and their effect on racial health disparities. The studies, published in American Journal of Human Biology, suggest that the higher rates of hypertension and cardiovascular disease present in African Americans may be a consequence of low birth weights, and that these low birth weights may be a result of social rather than genetic factors. More at...
Subscribe to:
Posts (Atom)
